Recent News

Biovance Capital Partners, a new venture capital company is launched by Bionova Capital’s team

Bionova Capital’s portfolio company Delox secures € 750,000

Bionova Capital’s portfolio company Adapttech raises £2.3 million and launches new prosthetic-fitting technologies

Bionova Capital announces new Scientific Advisory Board

Adapttech’s CEO Frederico Carpinteiro named to Forbes 30 under 30

Bionova Capital’s portfolio company Adapttech secures £2.0 million

Bionova Capital invests in Vaxdyn to develop a new vaccine against deadly bacteria

Hovione Capital becomes Bionova Capital and expands focus

Hovione Capital-backed startup Anybrain secures €1.0 million in funding

Hovione Capital and Portugal Ventures invest in CellmAbs, a Startup developing novel cancer therapies

Hovione Capital organized the largest-ever Healthcare Investor Conference in Portugal

Hovione Capital organizes the largest-ever Healthcare Investor Conference in Portugal

i3S-Hovione Capital Healthcare Innovation Prize

Hovione Capital appoints Dr. Ricardo Perdigão Henriques as CEO

Will chronic wounds have a better treatment? SolasCure, a new company in Hovione Capital’s portfolio

Delox: a unique technology for bio-decontamination and a new company in Hovione Capital’s portfolio

Adapttech: born in Portugal, raised in Europe and growing globally after securing £1.3M round!